Cargando…

Timing of COVID-19 vaccine approval and endorsement by public figures

The global spread of COVID-19 has created an urgent need for a safe and effective vaccine. However, in the United States, the politicization of the vaccine approval process, including which public figures are endorsing it, could undermine beliefs about its safety and efficacy and willingness to rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokemper, Scott E., Huber, Gregory A., Gerber, Alan S., James, Erin K., Omer, Saad B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744009/
https://www.ncbi.nlm.nih.gov/pubmed/33390295
http://dx.doi.org/10.1016/j.vaccine.2020.12.048
_version_ 1783624347749974016
author Bokemper, Scott E.
Huber, Gregory A.
Gerber, Alan S.
James, Erin K.
Omer, Saad B.
author_facet Bokemper, Scott E.
Huber, Gregory A.
Gerber, Alan S.
James, Erin K.
Omer, Saad B.
author_sort Bokemper, Scott E.
collection PubMed
description The global spread of COVID-19 has created an urgent need for a safe and effective vaccine. However, in the United States, the politicization of the vaccine approval process, including which public figures are endorsing it, could undermine beliefs about its safety and efficacy and willingness to receive it. Using a pair of randomized survey experiments, we show that announcing approval of a COVID-19 vaccine one week before the presidential election compared to one week after considerably reduces both beliefs about its safety and efficacy and intended uptake. However, endorsement by Dr. Anthony Fauci increases confidence and uptake among all partisan subgroups. Further, an endorsement by Dr. Fauci increased uptake and confidence in safety even if a vaccine receives pre-election approval. The results here suggest that perceptions of political influence in COVID-19 vaccine approval could significantly undermine the viability of a vaccine as a strategy to end the pandemic.
format Online
Article
Text
id pubmed-7744009
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-77440092020-12-17 Timing of COVID-19 vaccine approval and endorsement by public figures Bokemper, Scott E. Huber, Gregory A. Gerber, Alan S. James, Erin K. Omer, Saad B. Vaccine Article The global spread of COVID-19 has created an urgent need for a safe and effective vaccine. However, in the United States, the politicization of the vaccine approval process, including which public figures are endorsing it, could undermine beliefs about its safety and efficacy and willingness to receive it. Using a pair of randomized survey experiments, we show that announcing approval of a COVID-19 vaccine one week before the presidential election compared to one week after considerably reduces both beliefs about its safety and efficacy and intended uptake. However, endorsement by Dr. Anthony Fauci increases confidence and uptake among all partisan subgroups. Further, an endorsement by Dr. Fauci increased uptake and confidence in safety even if a vaccine receives pre-election approval. The results here suggest that perceptions of political influence in COVID-19 vaccine approval could significantly undermine the viability of a vaccine as a strategy to end the pandemic. Elsevier Ltd. 2021-01-29 2020-12-16 /pmc/articles/PMC7744009/ /pubmed/33390295 http://dx.doi.org/10.1016/j.vaccine.2020.12.048 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bokemper, Scott E.
Huber, Gregory A.
Gerber, Alan S.
James, Erin K.
Omer, Saad B.
Timing of COVID-19 vaccine approval and endorsement by public figures
title Timing of COVID-19 vaccine approval and endorsement by public figures
title_full Timing of COVID-19 vaccine approval and endorsement by public figures
title_fullStr Timing of COVID-19 vaccine approval and endorsement by public figures
title_full_unstemmed Timing of COVID-19 vaccine approval and endorsement by public figures
title_short Timing of COVID-19 vaccine approval and endorsement by public figures
title_sort timing of covid-19 vaccine approval and endorsement by public figures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744009/
https://www.ncbi.nlm.nih.gov/pubmed/33390295
http://dx.doi.org/10.1016/j.vaccine.2020.12.048
work_keys_str_mv AT bokemperscotte timingofcovid19vaccineapprovalandendorsementbypublicfigures
AT hubergregorya timingofcovid19vaccineapprovalandendorsementbypublicfigures
AT gerberalans timingofcovid19vaccineapprovalandendorsementbypublicfigures
AT jameserink timingofcovid19vaccineapprovalandendorsementbypublicfigures
AT omersaadb timingofcovid19vaccineapprovalandendorsementbypublicfigures